| ||||||||||||||||
| ||||||||||||||||
— FTC —Top tagsYou have executed a tag search on The Deal Newsweekly. To the right you will find a comprehensive list of stories tagged "FTC." Below are the most-popular tags for The Deal Newsweekly. On the right of the page you will find a search box to dig deeper into our content.
Community
 Entries tagged "FTC"A new map?The DOJ and FTC consider revised deal guidelines. Hit the booksA merger divestiture study would give antitrust agencies data to assess the value of requiring asset sales. An undiscovered countryJonathan Leibowitz's call to expand a rarely used provision of the FTC Act sparks alarm among business leaders. One annoying sweetheartThe FTC tries finally to end Generics' pay-for-delay Deals with branded pharma. But will it survive the healthcare reform? The 'pay for delay' debateFTC Chairman Jon Leibowitz has urged Congress to pass controversial legislation amending the antitrust laws to prohibit 'reverse payment' or 'pay for delay' patent settlements between branded and generic pharma companies. All in the familyThe Obama administration's problem is how to make merger investigations more uniform within the FTC and the DOJ. Antitrust 2.0The return of tech dealmaking brings with it a revived threat of scrutiny. Antitrust's next frontier?The DOJ's new competition chief, Christine Varney, considers a stronger antitrust role in the financial sector. Network buysAs digital advertising rapidly evolves, a surge of dealmaking and consolidation begins, but like everything else in advertising, it's a little unclear what it all means. New faces, new directionAntitrust mavens expect a more aggressive stance from the Department of Justice and the Federal Trade Commission. Time to thinkThe deal slowdown offers antitrust regulators an opportunity to rework merger guidelines. An innovative end runIn D.C.'s suburbs, the FTC wins a skirmish for hospital competition but a bigger battle may be lost. Two-track mindsWith the Whole Foods challenge, the FTC has aroused the anger of opponents of in-house trials. Movers & shakers: Jan. 8, 2009Following Robert McCann's surprising departure, Bank of America Corp.'s newly acquired Merrill Lynch & Co. named Daniel Sontag as head of its wealth management group.... In Obama we antitrustAn examination of merger clearance under the new administration. Obama's antitrust revivalThe recession and struggling companies may hamstring the president-elect's ability to say no to mergers. Quality judgmentsAssessments of hospital care improvements are increasingly critical in merger assessments and for healthcare reform. Part 3, the next chapterThe FTC's campaign to resurrect in-house merger litigation revives a debate over fairness. Economist in chiefThe new president and his economic team face daunting issues that leave no time for dallying. Here are some clues for what to expect in the early days of the Barack Obama administration. The thrill of speedEmboldened by a fast-track win, the FTC readies a spate of merger challenges. Recovery roomHere's a look at the evolution of the FTC's regulatory strategy in hospital mergers. About SchmidtThe FTC's former competition chief Jeffrey Schmidt moves to Linklaters and New York. This summer's potboilerStrong words from a split appeals court give the FTC and Whole Foods plenty of reason to settle before things go too far. Movers & shakers: Aug. 8, 2008Linklaters LLP announced that Jeffrey Schmidt, director of the Bureau of Competition of the Federal Trade Commission, will join the firm's New York office as... Reconcilable differencesThe breakup of a hospital takeover shines a light on the controversial twists of the FTC merger review process. | ||||||||||||||||
|
|
|
|
|
